Back to database
3.5/5 Moderate evidence

Stress & mood evidence brief

St John's wort

St John's wort has clinical evidence for mild to moderate depression symptoms, but the interaction risk is high enough that it should not be casually recommended.

Effective but interaction-limited health 6 linked sources Content audit 2026-05-05

Headline Finding

Cochrane review: 29 trials with 5,489 patients found tested extracts superior to placebo and similar to standard antidepressants in studied settings.

Dose Context

Trial results apply to standardized extracts, not arbitrary herbal blends. Dosing and hyperforin content strongly affect both efficacy and interaction risk.

Important Caveat

High interaction risk with antidepressants, oral contraceptives, anticoagulants, transplant drugs, HIV drugs, and many others. Clinical supervision is essential.

Source Drawer

Linked Research

6 papers and evidence links - audit 2026-05-05
  1. Review NCCIH St John's wort overview
  2. Review Cochrane depression review
  3. Review Cochrane plain-language review
  4. Systematic review Drug-interaction systematic review
  5. Systematic review CYP3A systematic review
  6. Review Clinical interaction review

How To Read This Rating

The score reflects evidence that the supplement does its stated job. Some jobs are direct, such as strength, endurance, or recovery; others are indirect, such as sleep, mood, appetite, or health support. A real effect can still receive a cautious practical rating when dose, safety, product quality, or audience fit remain uncertain.

Spot An Evidence Issue?

Send the disputed claim, source link, and why it changes the practical verdict. Corrections that materially affect the claim, dose, caveat, or rating are prioritized.

Report a source or rating issue